Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what role Price Waterhouse Coopers have been assigned in assisting with the financial management of the Mid & South Essex NHS Hospitals Trust; how long this task has been assigned for; what the cost to the public purse is; and what outputs they are required to deliver.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
PricewaterhouseCoopers (PwC) received a direct award to undertake a nationally mandated Investigation and Intervention programme at the Mid and South Essex Integrated Care Board, to support it in delivering its financial plan.
The programme lasted eight weeks, and the cost of phase one was £246,187, which the Mid and South Essex NHS Foundation Trust and the integrated care board incurred. The output was a report recommending actions the system should take to recover its in-year plan.
The Mid and South Essex Integrated Care Board decided to secure additional support from PwC for phase two from mid-July to the end of October 2024, which cost £1.07 million. This evolved into a programme of work supporting direct intervention within and across the foundation trust’s hospital sites.
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the salary bands are for the Managing Director of (a) Southend Hospital, (b) Basildon Hospital and (c) Broomfield hospital; and when the people in these roles were appointed.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department does not hold the information requested. Information on the renumeration and biographies of senior staff are published by hospital trusts as part of their annual report and accounts. This information for the Mid and South Essex Hospitals Trust, including biographies of senior staff, is available at the following link:
https://www.mse.nhs.uk/trust-publications-and-reports?smbfolder=150
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what the salary bands are for the (a) Chief Executive, (b) Chief Operating Officer, (c) Finance Director and (d) Medical Director at Mid & South Essex Hospitals NHS Trust.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
Information on the renumeration of senior staff is published by hospital trusts as part of their annual report and accounts. This information for the Mid and South Essex Hospitals Trust is available at the following link:
https://www.mse.nhs.uk/trust-publications-and-reports?smbfolder=150
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many (a) communications and (b) media staff are employed by Mid & South Essex Hospitals NHS Trust.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department does not hold the information requested.
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many equality, diversity and inclusion managers are employed by the Mid and South Essex Hospitals NHS Trust.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
The Department does not hold the information requested.
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the adequacy of five-year survival rates for (a) acute myeloid leukaemia and (b) other leukaemias.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
The age-standardised, one-year net survival for adults, those aged 15 to 99 years old, diagnosed with leukaemia between 2016 and 2020 in England was 74.4%, and the five-year survival rate was 55.9%.
NHS England has implemented non symptom specific pathways for patients who present with non-specific symptoms or combinations thereof, that can indicate several different cancers. This includes leukaemia, which can present non-specific symptoms, such as unexpected weight loss and night sweats. The national evaluation showed that blood cancers are one of the most common cancer types diagnosed through these pathways.
Raising awareness, delivering more research, including into new treatments, and improving early diagnosis of cancers, which includes blood related cancers such as leukaemia, are crucial for improving cancer survival.
Cancer patients are being failed, waiting too long for a diagnosis and treatment. We will bring down waits for cancer appointments with the Fit For the Future fund, doubling the number of state-of-the-art magnetic resonance imaging and computed tomography in the National Health Service to ensure early diagnosis and faster treatment.
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans he has to implement a cancer strategy over the course of this Parliament.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
Professor Lord Darzi is currently undertaking an independent investigation into the state of the National Health Service, the findings of which will feed into the Government’s 10-year plan to build a health service that is fit for the future. The Government will set out any further priorities on cancer and health in due course.
The NHS Long-Term Plan, published in January 2019, sets out the NHS’s key ambitions on cancer. The plan sets out the ambition to increase the number of cancers diagnosed at stage one and two to 75% by 2028, and to increase the number of people surviving cancer for five years by 55,000 as a result.
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether the evaluation of non-specific pathways will include granular blood cancer data.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
Raising awareness, delivering more research, including into new treatments, and improving early diagnosis of cancers, which includes blood related cancers such as leukaemia, are crucial for improving cancer survival.
NHS England has implemented non-symptom specific pathways for patients who present with non-specific symptoms, or combinations thereof, that can indicate several different cancers. This includes leukaemia, which can present non-specific symptoms, such as unexpected weight loss and night sweats. Using its national evaluation, NHS England has determined that blood cancers are one of the most common cancer types diagnosed through these pathways.
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what proportion of leukaemia patients were offered a holistic needs assessment in the last 12 months.
Answered by Karin Smyth - Minister of State (Department of Health and Social Care)
NHS England has committed to ensuring that all cancer patients have access to a Holistic Needs Assessment, ensuring care is focused on what matters most to each person.
The 2023 England National Cancer Patient Experience Survey indicates the proportion of people with Leukaemia who reported having had a discussion with a member of the team looking after them, before their treatment started, about their needs or concerns was 72.6%. For people with Leukaemia, a further 24.5% said they had the discussion to some extent, and a total of 97.1% reported having had a discussion.
Asked by: Mark Francois (Conservative - Rayleigh and Wickford)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what plans he has to develop a best practice pathway for (a) leukaemia and (b) other blood cancers.
Answered by Andrew Gwynne - Parliamentary Under-Secretary (Department of Health and Social Care)
NHS England has implemented non-symptom specific pathways for patients who present with symptoms that can indicate several different cancers, including leukaemia. An NHS England national evaluation showed blood cancers are one of the most common cancer types diagnosed through these pathways.